Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About


Published February 8, 2021
Published February 8, 2021

Amyris, a leading synthetic biotechnology company active in the Clean Health and Beauty markets, will expand its portfolio of consumer brands through the acquisition of Terasana.

WHO: Terasana is a natural skincare brand that is 100% vegan, cruelty free, and untouched by harmful chemicals. The brand was launched by Eric Kuskey, president of Manhattan Avenue Brands, Tina Rocca, founder of Aroma Naturals Candles that was acquired by Yankee Candle, Jeff Smith, CEO of CreateTribe and co-founder of, and Philip Zellner, CEO of Lighthouse Beauty Marketing.

Amyris is a science and technology leader in the research, development, and production of sustainable ingredients for the Clean Health and Beauty and Flavors & Fragrances markets. Amyris uses an array of exclusive technologies, including state-of-the-art machine learning, robotics, and artificial intelligence.

WHY: This deal will further expand Amyris’ presence in the clean beauty space and will expand its portfolio of consumer brands beyond its Biossance skincare, Pipette baby and mother care, and Rose Inc. clean cosmetics. The brand recently announced a partnership with Queer Eye star Jonathan Van Ness for a new clean haircare brand.

IN THEIR OWN WORDS: “We are very pleased with the early clinical results demonstrating Amyris CBG benefits including enhanced performance when combined with squalane. We are excited to lead the cannabinoid industry with science-backed, sustainably and cost-effectively sourced minor cannabinoids delivering outstanding performance for consumers and our planet,” said John Melo, President and Chief Executive Officer of Amyris. “During the fourth quarter of 2020, we sold out our entire first industrial production of clean CBG as an ingredient for use in flavors and fragrances. We are very optimistic about the future of clean cannabinoids and the efficacy they can bring to skincare as a logical extension to our existing consumer portfolio. Amyris’s consumer business is nearly half of total product revenue and represents the fastest growing business activity in our portfolio.”


  • This is the first acquisition of a brand by Amyris and will expand its portfolio of brands into the CBD space launching a new range of Terasana-branded clean beauty products focused on sustainably sourced natural cannabinoids.
  • Enabled by its proprietary Lab-to-Market synthetic biology platform, Amyris has a track record of developing and producing platform molecules from naturally sourced sugarcane and a sustainable fermentation production process. Through this platform, Amyris recently commercialized a clean, sustainable, fermentation-based CBG (cannabigerol), a non-psychoactive cannabinoid.

2 Article(s) Remaining

Subscribe today for full access